Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

TARO-CLARITHROMYCIN 500 MG — DIN 02361434

CLARITHROMYCIN : 500 MG · SUN PHARMA CANADA INC · TABLET · wholesale supply in Canada

Health Canada status: MARKETED

What is TARO-CLARITHROMYCIN?

TARO-CLARITHROMYCIN 500 MG contains CLARITHROMYCIN : 500 MG. It is listed in the Health Canada Drug Product Database under DIN 02361434, held by SUN PHARMA CANADA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 22-Mar-2024. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

How much does Clarithromycin cost around the world?

Clarithromycin is listed on 12 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.

What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.

MarketPrice basis published thereBrandsPacks listedRange
Saudi Arabiapublic4045SAR███.██
South Africasingle exit price3339ZAR███.██
Greeceproducer price (ex-factory)3030EUR███.██
Czechiamax producer price (ex-factory)829CZK███.██
United Statesacquisition425USD███.██
Bahrainretail (max)1424BHD███.██
Romaniamax producer price1623RON███.██
United Arab Emiratespublic1821AED███.██
AustriaKVP (Kassenverkaufspreis)1521EUR███.██
Luxembourgreimbursement1010EUR███.██
United Kingdomhospital66GBP███.██
Australiaex-manufacturer45AUD███.██

278 pack listings across 198 brand entries and 11 price bases, refreshed 08 Sep 2026. Ranges span every Clarithromycin pack in that market, so a high figure is usually a larger pack rather than the same product.

Figures are held for the Nexara team. Cross-market prices are published on incompatible bases and are not an offer, a landed cost, or a guide to what any buyer can obtain. Nexara publishes which markets list the product and on what basis; the numbers stay internal.

Team sign-in

Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.

Ask Nexara for a landed Canadian price

Is there a generic Clarithromycin in Canada, and who makes it?

Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.

17 holders have a Canadian DIN containing Clarithromycin, across 45 DINs, of which 21 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.

Market authorization holderDINsMarketedBrand namesPosition
BGP PHARMA ULC54BIAXIN, BIAXIN BID, BIAXIN XLSourceable in Canada
APOTEX INC33APO-CLARITHROMYCIN, APO-CLARITHROMYCIN XLSourceable in Canada
SUN PHARMA CANADA INC52RAN-CLARITHROMYCIN, TARO-CLARITHROMYCIN, TARO-CLARITHROMYCIN XLSourceable in Canada
SANIS HEALTH INC42CLARITHROMYCINSourceable in Canada
SANDOZ CANADA INCORPORATED32SANDOZ CLARITHROMYCIN, SANDOZ CLARITHROMYCIN XLSourceable in Canada
PRO DOC LIMITEE22CLARITHROMYCINSourceable in Canada
SIVEM PHARMACEUTICALS ULC22CLARITHROMYCINSourceable in Canada
TARO PHARMACEUTICALS INC22TARO-CLARITHROMYCINSourceable in Canada
TEVA CANADA LIMITED31TEVA-CLARITHROMYCIN, TEVA-CLARITHROMYCIN XLSourceable in Canada
MANTRA PHARMA INC21M-CLARITHROMYCINSourceable in Canada
LABORATOIRE RIVA INC.30RIVA-CLARITHROMYCINNo marketed DIN
AVANSTRA INC20AVA-CLARITHROMYCINNo marketed DIN

Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.

How is it supplied and stored?

Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.

Strength on the label500 MG
Dosage formTABLET
RouteORAL

Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.

Substance and classification

Active substanceClarithromycin
ATC codeJ01FA09
AHFS class08:12.12.08
Biosimilar biologicNo

Confirm the pack and get a price

Health Canada record and identifiers

The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.

DIN (8-digit, as used in ordering)02361434
DIN (unpadded, as printed on some documents)2361434
Brand nameTARO-CLARITHROMYCIN
Generic / active ingredientCLARITHROMYCIN : 500 MG
Market authorization holderSUN PHARMA CANADA INC
Health Canada schedulePrescription
ATC codeJ01FA09
ATC anatomical main groupJ — Anti-infectives for systemic use
ATC therapeutic subgroupJ01FA
Current statusMARKETED
Status date22-Mar-2024
Original market date2011-02-01 00:00:00
Status sourceLive Health Canada DPD sync

Verify on the primary sources

Health Canada DPD record Approved product monograph (PDF)

What can be used instead?

Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.

1 · Same molecule, other Canadian presentations

21 of 45 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.

ProductStrengthFormHolderHealth Canada statusDIN
APO-CLARITHROMYCIN500 MGTABLETAPOTEX INCMARKETED02274752
APO-CLARITHROMYCIN250 MGTABLETAPOTEX INCMARKETED02274744
APO-CLARITHROMYCIN XL500 MGTABLET (EXTENDED-RELEASE)APOTEX INCMARKETED02413345
BIAXIN125 MG / 5 MLGRANULES FOR SUSPENSIONBGP PHARMA ULCMARKETED02146908
BIAXIN250 MG / 5 MLGRANULES FOR SUSPENSIONBGP PHARMA ULCMARKETED02244641
BIAXIN BID500 MGTABLETBGP PHARMA ULCMARKETED02126710
BIAXIN BID250 MGTABLETBGP PHARMA ULCMARKETED01984853
CLARITHROMYCIN250 MGTABLETPRO DOC LIMITEEMARKETED02324482
CLARITHROMYCIN500 MGTABLETPRO DOC LIMITEEMARKETED02324490
CLARITHROMYCIN250 MGTABLETSIVEM PHARMACEUTICALS ULCMARKETED02442469

2 · Same class — other molecules in ATC J01FA

MoleculeCanadian brandsDINsMarketedSourceable
AzithromycinACT AZITHROMYCIN · AG-AZITHROMYCIN · APO-AZITHROMYCIN · APO-AZITHROMYCIN Z · AURO-AZITHROMYCIN · AVA-AZITHROMYCIN · AZITHROMYCIN · AZITHROMYCIN FOR INJECTION · AZITHROMYCIN FOR INJECTION USP · AZITHROMYCIN FOR INJECTION, USP · DOM-AZITHROMYCIN · GD-AZITHROMYCIN · IPG-AZITHROMYCIN · JAMP-AZITHROMYCIN · M-AZITHROMYCIN · MAR-AZITHROMYCIN · MYLAN-AZITHROMYCIN · NOVO-AZITHROMYCIN PEDIATRIC · NRA-AZITHROMYCIN · PHL-AZITHROMYCIN · PMS-AZITHROMYCIN · PRO-AZITHROMYCINE · RATIO AZITHROMYCIN · RIVA AZITHROMYCIN · RIVA-AZITHROMYCIN · SANDOZ AZITHROMYCIN · TEVA-AZITHROMYCIN · ZITHROMAX · ZITHROMAX - PWS ORL 100MG/5ML · ZITHROMAX 600MG · ZITHROMAX CAP 250MG · ZITHROMAX FOR INTRAVENOUS INJECTION · ZMAX SR8423Yes
ClarithromycinAPO-CLARITHROMYCIN · APO-CLARITHROMYCIN XL · AVA-CLARITHROMYCIN · BIAXIN · BIAXIN BID · BIAXIN XL · CLARITHROMYCIN · DOM-CLARITHROMYCIN · M-CLARITHROMYCIN · MYLAN-CLARITHROMYCIN · PMS-CLARITHROMYCIN · RAN-CLARITHROMYCIN · RATIO-CLARITHROMYCIN · RIVA-CLARITHROMYCIN · SANDOZ CLARITHROMYCIN · SANDOZ CLARITHROMYCIN XL · TARO-CLARITHROMYCIN · TARO-CLARITHROMYCIN XL · TEVA-CLARITHROMYCIN · TEVA-CLARITHROMYCIN XL4521Yes
ErythromycinALTI-ERYTHROMYCIN TAB 250MG USP · EES 600 TABLETS 600MG · EES-200 · EES-200 CHEWABLE TBS (ERYPED) · EES-400 · EMYCIN ECT 250MG · ERYBID · ERYC DELAYED-RELEASE CAPSULES · ERYTHRO-500 TAB 500MG USP · ERYTHRO-BASE · ERYTHRO-BASE TAB 250MG USP · ERYTHRO-EC · ERYTHRO-ES · ERYTHRO-ES TAB 600MG USP · ERYTHRO-S · ERYTHROCIN FILMTAB 250MG · ERYTHROCIN FILMTAB 500MG · ERYTHROCIN I.V. · ERYTHROCIN IV · ERYTHROCIN LIQ 250 · ERYTHROCIN LIQUID 125 · ERYTHROMID TAB 250MG · ERYTHROMYCIN CAPSULES USP 250MG · ERYTHROMYCIN STEARATE TABLETS USP 250MG · ERYTHROMYCINE 250 TAB · ILOSONE 250MG PULVULE 375 · ILOSONE LIQUID 125MG/5ML · ILOSONE LIQUID 250MG/5ML · ILOTYCIN GLUCEPTATE INJ 500MG/30ML · ILOTYCIN GLUCEPTATE IV AMPOULE 646 1GM · NOVO-RYTHRO ENCAP 250MG · NOVO-RYTHRO ESTOLATE CAP 250MG · NOVO-RYTHRO ESTOLATE SUSPENSION · NOVO-RYTHRO ETHYLSUCCINATE PWR 400MG/5ML · NOVO-RYTHRO ETHYLSUCCINATE PWS · NOVO-RYTHRO STEARATE TAB 250MG · NU-ERYTHROMYCIN-S 250MG TABLETS · PCE · STERILE ERYTHROMYCIN LACTOBIONATE PWS 1000MG · STERILE ERYTHROMYCIN LACTOBIONATE PWS 500MG472Yes
SpiramycinROVAMYCINE 250 CAPSULE 750000 UNIT · ROVAMYCINE 500 CAPSULE 1500000 UNIT20Not in Canada
TelithromycinKETEK10Not in Canada

A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.

3 · Adjacent classes in ATC J01F

ATC subgroupMoleculesDINsMarketed
J01FFClindamycin · Lincomycin6124
J01FGQuinopristin And Dalfopristin10

Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.

What else is TARO-CLARITHROMYCIN called?

The same molecule, Clarithromycin, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:

NameScriptRegistered in
KlacidLatinAustralia, Bahrain, Czechia
FROMILIDLatinCzechia
CLARIDARLatinBahrain, Saudi Arabia
CLARITHROMYCIN TEVALatinCzechia
KLACID SRLatinCzechia
CLARITHROMYCIN OLIKLALatinCzechia
CLARITTLatinBahrain
CLARITT XLLatinBahrain
Claritt® XLLatinUnited Arab Emirates
CLARIVALatinBahrain
FROMILID UNOLatinCzechia
KLACID-XLLatinBahrain
SPECTROMAXLatinBahrain
CLAREXLatinBahrain
ClaribaxLatinSouth Africa

Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for TARO-CLARITHROMYCIN

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Why is there no price on this page?

Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Sources and disclaimer

Product data sourced from the Health Canada Drug Product Database and the approved product monograph (PDF). Health Canada status reconciled against the live DPD sync. Last reviewed 10 Sep 2026.

Nothing on this page is medical advice. Nexara Health is a licensed wholesale distributor and supplies licensed entities only; consumer orders are routed to a partner pharmacy. Alternatives tables describe supply, not clinical equivalence.

Health Canada Drug Product Database (DPD), DIN 02361434. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.